Meta‐analysis of the efficacy of the acetonic kava‐kava extract WS®1490 in patients with non‐psychotic anxiety disorders

@article{Witte2005MetaanalysisOT,
  title={Meta‐analysis of the efficacy of the acetonic kava‐kava extract WS®1490 in patients with non‐psychotic anxiety disorders},
  author={S. Witte and D. Loew and W. Gaus},
  journal={Phytotherapy Research},
  year={2005},
  volume={19}
}
  • S. Witte, D. Loew, W. Gaus
  • Published 2005
  • Medicine
  • Phytotherapy Research
  • Introduction: The herbal medicinal product kava‐kava, used for treating anxiety disorders, was assessed positively by the Cochrane Review. However, it was withdrawn from the market in Switzerland and Germany due to cases of liver failure and ‘unproven’ efficacy. 
    50 Citations

    Paper Mentions

    NEWS ARTICLE
    Kava as a Clinical Nutrient: Promises and Challenges
    Toxicokinetics of Kava
    • 65
    • PDF
    Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology
    • 100
    Review of clinical studies of Polygonum multiflorum Thunb. and its isolated bioactive compounds
    • 54
    Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
    • 295
    • PDF

    References

    SHOWING 1-10 OF 12 REFERENCES
    Kava treatment in patients with anxiety
    • 36
    Kava extracts: safety and risks including rare hepatotoxicity.
    • 109
    Kava and Valerian in the treatment of stress‐induced insomnia
    • 58
    Kava--the unfolding story: report on a work-in-progress.
    • 75
    • PDF